Datamonitor\'s new premium tool, "DiseaseFocus Oncology," includes epidemiology and drug treatment forecasts which are designed to reliably assess the current & future magnitude of patient treatment opportunities across multiple cancer types in the seven major markets. Tumors covered include: Prosate, Breast, NSCLC, NHL, Bladder, Colon & Rectal, Multiple Myeloma, and Renal Cell Carcinoma

1. Access superior oncology epidemiology and
treatment data with DiseaseFocus
The DiseaseFocus portfolio includes epidemiology (EpiFocus) and drug treatment (TreatmentFocus) forecasts which are designed to
reliably assess the current and future magnitude of patient treatment opportunities across multiple cancer types in seven major markets.
Why does DiseaseFocus offer How will data with Greater Accuracy
Greater Accuracy? help me?
Datamonitor identified a gap in the market for a robust With more accurate data, DiseaseFocus allows you to make
bottom-up forecasting technique that provides pharmaceutical crucial business decisions from a position of strength.
companies with more accurate data and greater granularity. Our
audited techniques are unique in a market dominated by top • Better prioritization of drug development and clinical trials
down general forecasts. • Deploy resources to where they will generate the most return
Patients on drug X • Rank indications and patient segments based on more
TreatmentFocus accurate figures of current size and expected growth and value
• Gain a full understanding of the threats posed by current
Drug-treated patients
and future potential competitors based on their drugs – both
Bottom-up forecasting
currently marketed and in development
Treatable population • Accurately evaluate in- or out-licensing opportunities
EpiFocus
Population with disease
Total population

2. EpiFocus Database
The EpiFocus Database is Datamonitor’s proprietary epidemiology database providing robust and comprehensive
epidemiologic data for the seven major healthcare markets, forecast over a ten-year period.
Our epidemiology product is uniquely packaged to allow you to maximize the potential of our extensive patient-level and population-
level data. You can choose from a variety of epidemiologic measures and variables to create your own tailored data outputs. All
data has been rigorously assessed for robustness and validated for accuracy by our team of highly qualified and experienced
epidemiologists, so you can be sure that you are working with trustworthy information.
TreatmentFocus Database
The TreatmentFocus Database provides comprehensive treatment data for the seven major healthcare markets, forecast
over a ten-year period. The TreatmentFocus Database uses the principles of bottom up forecasting based on Datamonitor’s
proprietary epidemiology offering (EpiFocus).
The TreatmentFocus Database is designed to facilitate easy access to comprehensive drug prescribing patterns across the seven
major healthcare markets. You can view the data by tumor type or by a single drug molecule segmented by clinically relevant
populations. Multiple data sources have been carefully selected and validated to build an accurate picture of current and future clinical
practice. All forecast assumptions are explained in detail and can be accessed from the TreatmentFocus Database front page.
Meet our Accuracy Experts
Lulit Solomon Andrew Paramore
Global Director of Epidemiology Head of Oncology Product Development
PhD and MPhil in Epidemiology (Cambridge University) MRPhamS
Lulit has extensive expertise in epidemiologic methods and Andrew has a BSc in Pharmacy and is currently studying for
analyses, with cross-disease experience and in-depth cancer an MSc in Clinical Oncology at Birmingham University. He has
epidemiology knowledge. extensive experience in oncology and haematology gained
during his time as a senior pharmacist at the Royal Marsden
Previously Lulit was Principal Epidemiologist at Decision
NHS Trust. He has pharmaceutical industry experience with
Resources where she was the in-house expert on epidemiology
a number of positions at GSK and Amgen UK. He has also
and supported the multi-syndicated and consulting businesses.
worked as a Healthcare Analyst specialising in oncology with
Lulit has also undertaken a variety of health strategy research
Decision Resources.
and consulting projects in a number of countries including
the UK, Canada, Malawi, Kenya, and Uganda. As a former
Honorary Fellow of the Cancer Intelligence Unit at Cambridge
University, Lulit maintains her strong academic links in the field
of epidemiology.
Free For more information on DiseaseFocus or to arrange
Demo a free demo please contact demo@datamonitor.com